Article info
Commentary
Myeloid-derived suppressor cells in pancreatic cancer: more than a hidden barrier for antitumour immunity?
- Correspondence to Professor Tim F Greten, Thoracic and Gastrointestinal Oncology Branch, Gastrointestinal Malignancy Section, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; tim.greten{at}nih.gov
Citation
Myeloid-derived suppressor cells in pancreatic cancer: more than a hidden barrier for antitumour immunity?
Publication history
- Received February 25, 2014
- Accepted February 26, 2014
- First published March 14, 2014.
Online issue publication
April 18, 2016
Article Versions
- Previous version (18 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions